CALIFORNIA STEM CELL INC
IRVINE, CA · CIK 0001375617 · Biotech · Acquired
Stem cell research and development services
california.space →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $1.9M
- 1 Form D · Feb 2012
- 176 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 19
- 1 granted · 18 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112012
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,950,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1468 | Nob Hill Therapeutics, Inc. | — | $2.2M |
| 1469 | Aptevo Therapeutics Inc. | — | $5.6M |
| 1470 | Up Therapeutics LLC | — | — |
| 1471 | CALIFORNIA STEM CELL INC | — | $1.9M |
| 1472 | Aptorum Group Ltd | — | $1.6M |
| 1473 | RESBIOTIC, INC. | — | $1.6M |
| 1474 | UBIVAC, INC. | — | $1.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Christopher AirriessDirector · Executive Officer
- David FroshDirector
- Hans KeirsteadDirector · Executive Officer
- Jason LivingstonExecutive Officer
- Mark SurfasDirector
Patents
- Antigen Presenting Cancer Vaccinegranted
- Pluripotent Germ Layer Origin Antigen Presenting Cancer Vaccineapplication
- High Purity Ovarian Cancer Stem Cells For Active Autologous Immune Therapyapplication
- Bioreactor Cartridge And Systemapplication
- Individualized High-purity Colon Carcinoma Stem Cells, Methods And Use Of The Sameapplication
- Individualized High-purity Glioblastoma Multiforme Stem Cells, And Methods For Stimulating Immune Responseapplication
- Individualized High-purity Ovarian Cancer Stem Cellsapplication
- Cell Populations For Vascular Mimicry, Preparation And Methods Of Useapplication
- Individualized High Purity Hepatocellular Carcinoma Stem Cells, Methods And Use Of The Sameapplication
- Gamma Interferon Treated Pluripotent Germ Layer Origin Antigen Presenting Cancer Vaccineapplication
- Pluripotent Germ Layer Origin Antigen Presenting Cancer Vaccineapplication
- Antigen Presenting Cancer Vaccine With Gamma Interferonapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.